0000929638-01-500233.txt : 20011119
0000929638-01-500233.hdr.sgml : 20011119
ACCESSION NUMBER: 0000929638-01-500233
CONFORMED SUBMISSION TYPE: SC 13D/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20011106
GROUP MEMBERS: AIM HIGH ENTERPRISES, INC.
GROUP MEMBERS: KAIROS PARTNERS GP, LLC
GROUP MEMBERS: KAIROS PARTNERS, LP
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUCOR INC
CENTRAL INDEX KEY: 0000736822
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 222408354
STATE OF INCORPORATION: GA
FISCAL YEAR END: 0531
FILING VALUES:
FORM TYPE: SC 13D/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-37473
FILM NUMBER: 1775729
BUSINESS ADDRESS:
STREET 1: 3130 GATWAY
STREET 2: PO BOX 5625
CITY: NORCROSS
STATE: GA
ZIP: 30091
BUSINESS PHONE: 7704412051
MAIL ADDRESS:
STREET 1: 3130 GATEWAY DR
STREET 2: P O BOX 5625
CITY: NORCROSS
STATE: GA
ZIP: 30091-5625
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: KAIROS PARTNERS LP
CENTRAL INDEX KEY: 0001122689
STANDARD INDUSTRIAL CLASSIFICATION: []
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13D/A
BUSINESS ADDRESS:
STREET 1: 600 LONGWATER DRIVE
STREET 2: SUITE 204
CITY: NORWELL
STATE: MA
ZIP: 02061
BUSINESS PHONE: 7816351100X1123
MAIL ADDRESS:
STREET 1: 600 LONGWATER DR.
STREET 2: SUITE 204
CITY: NORWELL
STATE: MA
ZIP: 02061
SC 13D/A
1
a1053264a.txt
SCHEDULE 13D AMENDMENT NO. 9
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(RULE 13D-101)
INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO 13D-1(A) AND AMENDMENTS
THERETO FILED PURSUANT TO 13D-2(A)
(AMENDMENT NO. 9)*
Immucor, Inc.
(Name of Issuer)
Common Stock, $.10 par value
(Title of Class of Securities)
452526106
(CUSIP Number)
James F. Rice, Managing Director
c/o Aim High Enterprises, Inc.
600 Longwater Drive, Suite 204
Norwell, MA 02061
(781) 635-1121
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
October 31, 2001
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
(Continued on the following pages)
(Page 1 of 9 Pages)
----------------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP No. 452526106 13D/A
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Kairos Partners, LP (Tax ID: 04-3521249)
Kairos Partners GP, LLC
Aim High Enterprises, Inc.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(A) [ ]
(B) x
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC--SEE ITEM 3
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(D) OR 2(E)
[ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION Kairos Partners, LP is a Delaware
limited partnership. Kairos Partners GP,LLC is a Delaware limited
liability corporation. Aim High Enterprises, Inc. is a Delaware
corporation.
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
NUMBER OF --------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 524,708 shares--See Item 5
EACH --------------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON WITH
None
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
524,708 shares--See Item 5
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
524,708 shares--See Item 5
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS) [ ]
Not Applicable.
--------------------------------------------------------------------------------
CUSIP No. 452526106 13D/A
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.21% (based on 7,277,617 shares of Common Stock outstanding as of
October 15, 2001, as reported by the Issuer in its proxy statement for
the annual meeting of the Issuer's stockholders to be held on November
30, 2001).
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
Kairos Partners, LP--PN
Kairos Partners GP, LLC--OO (limited liability company)
Aim High Enterprises, Inc.--CO
--------------------------------------------------------------------------------
ITEM 1. SECURITY AND ISSUER:
(a) This Amendment No.9 relates to the common stock, $.10 par value per
share, of Immucor, Inc. (the "Common Stock").
(b) The names and addresses of the principal executive officers of the
Issuer are as follows:
Edward L. Gallup, President and Chief Executive Officer
Ralph A. Eatz, Senior Vice President - Operations
Dr. Gioacchhino De Chirico, Director of European Operations and
President, Immucor Italia S.r.1
Steven C. Ramsey, Vice President - Chief Financial Officer and
Secretary
Patrick Waddy, President of Dominion Biologicals Limited and European
Finance Director
Address: c/o Immucor, Inc.
3130 Gateway Drive
P.O. Box 5625
Norcross, Georgia 30091
ITEM 2. IDENTITY AND BACKGROUND
1. (a) Kairos Partners, LP, ("Kairos") a limited partnership organized
under the laws of the State of Delaware.
(b) Address: c/o Aim High Enterprises, Inc.
600 Longwater Drive, Suite 204
Norwell, MA 02061
(c) Principal Business: Investments
(d) During the last five years, Kairos has not been convicted in a
criminal proceeding.
CUSIP No. 452526106 13D/A
(e) During the last five years, Kairos was not a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject
to, federal or state securities laws or finding any violation
with respect to such laws
2. (a) Kairos Partners GP, LLC, a limited liability corporation
organized under the laws of the State of Delaware ("Kairos GP").
Kairos GP is the general partner of Kairos.
(b) Address: c/o Aim High Enterprises, Inc.
600 Longwater Drive, Suite 204
Norwell, MA 02061
(c) Principal Business: Investments
(d) During the last five years, Kairos GP has not been convicted in
a criminal proceeding.
(e) During the last five years, Kairos GP was not a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject
to, federal or state securities laws or finding any violation
with respect to such laws
3. (a) Aim High Enterprises, Inc. controls Kairos GP.
(b) Address: Aim High Enterprises, Inc.
600 Longwater Drive, Suite 204
Norwell, MA 02061
(c) Principal Business: Investments
(d) During the last five years, Aim High Enterprises, Inc. has not
been convicted in a criminal proceeding.
(e) During the last five years, Aim High Enterprises, Inc. was not a
party to a civil proceeding of a judicial or administrative body
of competent jurisdiction and as a result of such proceeding was
or is subject to a judgment, decree or final order enjoining
future violations of, or prohibiting or mandating activities
subject to, federal or state securities laws or finding any
violation with respect to such laws.
(f) Aim High Enterprises, Inc. is a corporation organized under the
laws of the State of Delaware.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION:
The amount of funds used in acquiring the Common Stock was $1,998,025.99.
The source of these funds was Kairos' current cash equivalent assets (working
capital).
CUSIP No. 452526106 13D/A
ITEM 4. PURPOSE OF TRANSACTION:
At the time that Kairos acquired the shares of Common Stock which are
reported hereby, such shares were acquired for investment purposes. Kairos
reserves the right from time to time to acquire additional shares, or to
dispose of some or all of its shares.
(a) Not applicable.
(b) Not applicable.
(c) Not applicable.
(d) On October 7, 2001, Kairos filed a preliminary proxy statement with
the Securities and Exchange Commission relating to its solicitation of
proxies from the holders of Common Stock in favor of Kairos' nominees
for election to the Issuer's Board of Directors at the annual meeting
of Issuer's stockholders to be held on November 30, 2001. As
previously disclosed by Kairos, Kairos has nominated four individuals
to the Board of Directors of the Issuer. Based on the most recent
proxy statement filed by the Issuer, if elected, Kairos' nominees
would constitute a majority of the Issuer's Board of Directors. On
October 30, 2001, Kairos filed an amended preliminary proxy statement
with the Commission. On November 5, 2001, Kairos filed an amended
preliminary proxy statement with the Commission.
(e) Not applicable.
(f) Not applicable.
(g) Not applicable.
(h) Not applicable.
(i) Not applicable.
(j) Not applicable.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER:
(a) The following list sets forth the aggregate number and percentage
(based on 7,277,617 shares of Common Stock outstanding as of October 15, 2001,
as reported by the Issuer in its preliminary proxy statement relating to the
annual meeting of Issuer's stockholders to be held on November 30, 2001) of
CUSIP No. 452526106 13D/A
outstanding shares of Common Stock owned beneficially by each reporting person
named in Item 2, as of October 31, 2001:
--------------------------------------------------------------------------------
Name Shares of Common Stock Percentage of Beneficial
Beneficially Owned Ownership
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Kairos Partners, LP 524,708 7.21%
--------------------------------------------------------------------------------
Kairos Partners GP, LLC(1) 524,708 7.21%
--------------------------------------------------------------------------------
Aim High Partners, Inc.(1) 524,708 7.21%
--------------------------------------------------------------------------------
-----------------------
(1) The reporting person disclaims beneficial ownership of these securities
except to the extent of his/its equity interest therein.
(b) Kairos has sole power to vote and to dispose of 524,708 shares of
Common Stock, representing 7.21% of the outstanding Common Stock.
Kairos GP, by virtue of being the general partner of Kairos, may be
deemed to have shared power to vote and to dispose of 524,708 shares
of Common Stock, representing 7.21% of the outstanding Common Stock.
Aim High Enterprises, Inc., by virtue of its control of Kairos GP,
may be deemed to have shared power to vote and to dispose of 524,708
shares of Common Stock, representing 7.21 % of the outstanding
Common Stock.
(c) The following is a description of all transaction in shares of
Common Stock of the Issuer by the reporting person identified in
Item 2 of this Schedule 13D effected from October 22, 2001 to
October 31, 2001:
See Appendix A.
(d) Not applicable
(e) Not applicable
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER :
Not applicable.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
Exhibit 1 Preliminary Proxy Statement filed by Kairos with respect to
the solicitation of proxies in connection with the 2001
Annual Meeting of the Issuer, as amended (incorporated herein
by reference)
CUSIP No. 452526106 13D/A
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
November 6, 2001
-----------------------
(Date)
/s/ James F. Rice
-----------------------
(Signature)
By: James F. Rice
CUSIP No. 452526106 13D/A
Appendix A
--------------------------------------------------------------------------------------------------------
Name of Shareholder Date of Purchase or Number of Shares Purchase or Sale
Sale Purchased or (Sold) Price Per Share
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (7,500) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (7,200) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (7,100) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (6,900) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (6,700) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (5,900) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (5,600) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (5,600) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (5,000) $7.49
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (5,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (5,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (5,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (4,700) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (4,400) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (4,400) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (4,300) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (4,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (4,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (3,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (3,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (3,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (3,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (3,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (3,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (3,000) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (2,500) $7.49
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (2,500) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (2,300) $7.21
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (2,300) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (2,000) $7.49
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (2,000) $7.49
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (2,000) $7.49
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (1,800) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (1,500) $7.15
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (1,500) $7.14
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (1,500) $7.09
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (1,500) $7.09
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (1,500) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (1,400) $6.99
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (1,000) $7.04
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (900) $7.12
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (770) $7.05
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (600) $6.98
--------------------------------------------------------------------------------------------------------
CUSIP No. 452526106 13D/A
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (400) $6.96
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (200) $7.18
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (200) $6.96
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (200) $6.94
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (100) $7.06
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 (100) $6.93
--------------------------------------------------------------------------------------------------------
Kairos 10/31/01 1,000 $7.014
--------------------------------------------------------------------------------------------------------
The shares of Common Stock were purchased and sold by Kairos in the
over-the-counter market.